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Background: Asthma has rarely been studied by evaluating all of its trigger factors in 1 study population. Thus,
correlations between the concentration of allergen immunoglobulin (Ig) E antibodies and airway limitation or asthma
severity remain unclear.
Methods: Five hundred and seventy-nine asthmatic patients were enrolled, and serum specific IgE antibodies to allergens
were analyzed. All suspected trigger factors were assessed by questionnaire, case histories over a 4-year period, and
diary card recordings; possible trigger factors were then re-evaluated.
Results: Antibodies to the following allergens were found: Dermatophagoides pteronyssinus (59.8% of patients),
D. microceras (58.8%), D. farinae (56.8%), cockroach (38.3%), dog dander (26.3%), Candida albicans (13.3%), cat
dander (10%), and Cladosporium herbarum (6.6%). A greater prevalence of allergy to dog and cat dander was found
than previously. Younger patients were more often positive for mite allergens, and had higher titers of antibodies
against such allergens, than older patients. Further, females had a lower concentration of mite allergen antibodies
than males. No correlation between the concentration of allergen antibodies and forced expiratory volume in 1 second
(FEV1), or the ratio of FEV1:forced vital capacity (FEV1:FVC), was found. In addition, there was no significant change
in antibody titers with varying asthma severity. Non-allergenic trigger factors were irritant air inhalants (94.6% of
patients), respiratory infection (92.2%), exercise (75.2%), emotional factors (58.8%), drugs and chemical substances
(16%).
Conclusion: There are multiple trigger factors in asthma. Allergenic trigger factors are more common in younger
than older patients, whereas non-allergenic trigger factors are more common in older patients. There was no linear
correlation between the concentration of specific IgE antibodies and asthma severity or airway limitation; therefore,
to prevent asthma attacks in individual asthmatic patients, greater attention should be paid to avoiding all potential
trigger factors, and not just house dust mite allergens. [J Chin Med Assoc 2005;68(5):204–209]
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Introduction
Bronchial asthma is a chronic inflammatory disorder
of the airways that causes hyper-responsiveness of the
bronchial tree to various stimuli. Among the many
factors capable of triggering asthmatic symptoms,
specific allergen-immunoglobulin (Ig) E antibody
reactions still play one of the most important roles.1–3
Aside from allergens, other non-allergenic trigger
factors, such as respiratory infection, airborne particles,
emotional factors, and exercise, are also important in
inducing asthma attacks.4 Pharmacologic intervention
to treat established asthma is highly effective in
controlling symptoms and improving quality of life.
In addition, the most important aspect of asthma
management is to avoid exposure to trigger factors
and, thus, prevent asthma attacks; subsequently, the
control of asthma can be improved and medication
needs reduced.
In Taiwan, there has been no survey of allergenic
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trigger factors for asthma in a large population of
patients, and previous studies have focused more on
allergenic trigger factors, especially house dust mite
allergens, than non-allergenic factors. Thus,
information about non-allergenic trigger factors is
limited. Further, as no study has evaluated all trigger
factors for asthma in 1 population, correlations
between the concentrations of specific allergen IgE
antibodies and airway limitation or asthma severity
remain unclear.
In this study, we attempted to analyze the prevalence
of various trigger factors for asthma, related or unrelated
to allergens, in patients living in Taipei city, and to
determine whether correlations exist between the
concentrations of specific allergen antibodies and airway
limitation or asthma severity.
Methods
Study population
Five hundred and seventy-nine asthmatic patients,
who had been followed up regularly at the Asthmatic
Clinic of the Pulmonary Division of Tri-Service General
Hospital from January 1997 to December 2001, were
included in this investigation. The hospital review
board for human studies approved the protocols used,
and informed consent was obtained from each patient
before participation.
Study protocols
Bronchial asthma was diagnosed using Global Initiative
for Asthma (GINA) criteria:4 namely, a history of
recurrent, paroxysmal attacks (at least 3) of reversible
obstructive airway disease, which resolved either
spontaneously or after treatment with bronchodilators.
Pulmonary function tests, bronchodilation tests, and
methacholine bronchial provocation tests were per-
formed to confirm airway obstruction, reversibility of
obstruction, and hyper-responsiveness, respectively.
After pulmonary function tests, each patient
underwent serum assay for specific IgE antibodies to
the following common allergens: Dermatophagoides
pteronyssinus, D. farinae, D. microceras, cockroach,
cat dander, dog dander, Alternaria tenuis,
Cladosporium herbarum, and Candida albicans.
Antibody analysis was performed with the Pharmacia
CAP SystemTM (Pharmacia Diagnostics, Uppsala,
Sweden).
All CAP System assays were performed at the same
time, and in the same laboratory, according to
previously detailed techniques that employed an
immunoenzymatic method.5 Briefly, test sera were
incubated with the solid phase, consisting of a flexible
hydrophilic allergen carrier (polymer) encased in a
capsule (ImmunoCAPTM; Pharmacia Diagnostics).
This carrier comprises a cyanogen bromide-activated
cellulose derivative, which can bind at least 3 times
more antigen than the corresponding paper disk used
in the radioallergosorbent test (RAST), and up to 50
times more allergen than the amount adsorbed on a
coated tube. An anti-human IgE (polyclonal and
monoclonal) antibody mixture labeled with `-
galactosidase (generating fluorescence) was then added.
This reagent has high immunoreactivity and low
background, allowing a wider range of measurement
than in the RAST. Finally, the intensity of the resulting
color was measured in a spectrophotometer. The
entire procedure is automated. Results, expressed in
kilounits per liter (kU/L), were obtained by reference
to a standard curve derived from serial dilution of
human IgE calibrated against the World Health Orga-
nization standard for IgE. One kU/L corresponds to
2.4 ng of IgE per mL. A value * 0.35 kU/L is defined
as a positive CAP System result.
Asthma severity was assessed in terms of symptoms,
amounts of `2-agonist used to treat symptoms, and
lung function, and was subdivided into 4 categories
according to GINA criteria: mild intermittent, mild
persistent, moderate persistent, and severe persistent.4
The study questionnaire6 contained many items,
such as detailed general data, history of respiratory
symptoms and treatment of asthma, history of allergies
(e.g. allergic rhinitis, urticaria, and asthma), smoking
habit, genetic background in relatives, occupation
history, and a detailed checklist of previous exposure
to trigger factors (e.g. air stimulants, respiratory
infection, exercise, emotional factors, drugs, chemical
substances, etc.) and which ones had induced asthmatic
attacks in the past. The questionnaire was completed
at the Asthma Clinic by a nurse, with responses
subsequently confirmed by a doctor. In the following
years, patients were regularly followed-up in the
outpatient department.
Suspected previous trigger factors were confirmed
from diary card records, since these records may reveal
the factors responsible for a drop in peak expiratory
flow rate. Only 294 asthmatic patients agreed to
record daily asthma cards (i.e. symptom scores,
expiratory peak flow rate, and adverse effects of
antiasthmatic drugs).
Statistical analysis
Values for study parameters were expressed as mean (
standard deviation, or percent. Comparisons among
all groups for a given variable were performed using 1-
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way analysis of variance and Dunnett’s methods. A p
value < 0.05 was considered statistically significant.
Simple linear regression between forced expiratory
volume in 1 second (FEV1), or the ratio of FEV1:
forced vital capacity (FEV1:FVC), and concentration
of mite allergen antibodies was performed.
Results
Among the 579 patients enrolled, 294 agreed to
complete the questionnaire study: 139 males (43.7%)
and 155 females (52.7%); mean age, 42.7 years (range,
10–85 years). In these 294 asthmatic patients, 69.4%
had allergic rhinitis, 67.7% had a history of bronchial
asthma in relatives, 22.4% had atopic dermatitis, and
18% were smokers. The severity of bronchial asthma
was classified as mild intermittent in 37.1% of patients,
mild persistent in 11.9%, moderate persistent in
28.6%, and severe persistent in 19.4% (Table 1).
Case histories for the 294 asthmatic patients revealed
the following non-allergenic trigger factors: stimulant
inhalation (94.6% of patients); respiratory tract infection
(92.2%); exercise (75.2%); emotional factors (58.8%);
and chemical agents and drugs (18.0%) (Table 2).
Serum specific IgE antibodies to allergens in 579
asthmatic patients were analyzed, and the following
allergens were confirmed in the following proportions
of patients: D. pteronyssinus (59.8%), D. microceras
(58.8%), D. farinae (56.8%), cockroach (38.3%), dog
dander (26.3%), C. albicans (13.3%), cat dander (10%),
and C. herbarum (6.6%) (Table 3).
Increasing asthma severity was not significantly
related to IgE concentrations, or to the proportions of
patients positive for antibodies to mite allergens (Table
4). There were also no correlations between antibody
titers to mite allergens and FEV1 or FEV1:FVC. The
findings were also similar for other allergens (cockroach,
dog dander, cat dander, C. albicans, and C. herbarum).
Thus, no allergenic trigger factors independently
influenced asthma severity. However, rates of antibody
positivity and antibody titers correlated with age and
gender. In all age groups, the rate of antibody positivity
to D. pteronyssinus was greater in males than females
(Figure 1).
Table 1. Demographic data for the 294 asthmatic patients who completed the questionnaire study
Age distribution, yr
10–19 20–29 30–39 40–49 50–59 60–69 * 70
Number of patients (%) 30 (10.2) 61 (20.7) 36 (12.2) 65 (22.1) 35 (11.9) 37 (12.6) 30 (10.2)
Gender Heredity Smoking
Male Female Yes No Yes No
Number of patients (%) 139 (47.3) 155 (52.7) 199 (67.7) 95 (32.3) 53 (18.0) 241 (82.0)
Allergic history
Allergic rhinitis Dermatitis Other Total
Number of patients (%) 204 (69.4) 66 (22.4) 22 (7.5) 224 (76.2)
Asthma severity
Mild intermittent Mild persistent Moderate persistent Severe persistent Uncertain
Number of patients (%) 109 (37.1) 35 (11.9) 84 (28.6) 57 (19.4) 9 (3.1)
Figure 1. Rates of immunoglobulin E (IgE) antibody positivity against
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Table 2. Non-allergenic trigger factors in 294 asthmatic patients
Stimulant inhalation (278/294; 94.6%)
Weather change Cold air Air pollution Perfume
Number of patients (%) 225 (76.5) 203 (69.0) 155 (52.7) 79 (26.9)
Respiratory tract infection (271/294; 92.2%)
Upper respiratory tract Bronchitis Sinusitis Pneumonia
Number (%) of patients 255 (86.7) 124 (42.2) 52 (17.7) 20 (6.8)
Exercise (221/294; 75.2%)
Climbing stairs Running Walking Cycling Swimming Dancing Playing tennis
Number (%) of patients 160 (54.4) 154 (52.4) 45 (15.3) 27 (9.2) 25 (8.5) 19 (6.5) 17 (5.8)
Emotional factors (173/294; 58.8%)
Anger Laughing Vexation Nervousness Scared Shouting
Number (%) of patients 107 (36.4) 76 (25.9) 37 (12.6) 43 (14.6) 31 (10.5) 30 (10.2)
Chemical agents and drugs (46/294; 15.6%)
Aspirin Alcohol (wine) Surface conservative Yellow pigment Red pigment
Number (%) of patients 21 (7.1) 16 (5.4) 6 (2.0) 2 (0.7) 1 (0.3)
Table 3. Percentage of 579 asthmatic patients with positive status for antibodies to various allergens, and grades of
antibody positivity
Grade of antibody response* (% of patients)
1 2 3 4 5 6 Total
Allergen
Dermatophagoides pteronyssinus 4.3 10.7 26.9 12.1 12.3 7.4 59.8
Dermatophagoides microceras 5.1 10.4 2.7 13.4 13.6 3.7 58.8
Dermatophagoides farinae 4.3 10.5 12.3 12.3 11.2 6.2 56.8
Cockroach 13.5 16.9 7.3 0.6 0 0 38.3
Crab 10.4 12.8 4.9 1.0 0 0 29.2
Shrimp 10.0 11.8 5.5 0.3 0 0 27.7
Dog dander 8.7 11.7 3.0 1.8 1.0 0.2 26.3
Candida albicans 4.9 6.1 2.3 0 0 0 13.3
Cat dander 3.0 3.6 3.0 0 0.2 0.2 10.0
Cladosporium herbarum 3.3 1.8 1.5 0 0 0 6.6
Alternaria tenuis 2.0 1.4 0 0 0 0 3.5
*A positive antibody response (antibody concentration to allergen * 0.35 kU/L) was considered in 6 grades: grade 1 = 0.35–0.7 kU/L;
grade 2 = > 0.7–3.5 kU/L; grade 3 = > 3.5–17.5 kU/L; grade 4 = > 17.5–50 kU/L; grade 5 = > 50–100 kU/L; grade 6 = > 100 kU/L.
Discussion
Our results indicate that the house dust mite is the
most common allergen in asthmatic patients in Taiwan.
Younger versus older patients have higher rates of
antibody positivity, and higher titers of antibodies,
against mite allergens; indeed, the rate of antibody
positivity against D. pteronyssinus was 93.2% in patients
aged < 20 years, compared with a rate of only 45.9% in
patients aged 60–70 years. Further, rates of antibody
positivity against mite allergens were lower in females
than males.
Since the report of Voorhorst et al7 in 1967, D.
pteronyssinus and D. farinae have proved to be among
the most important allergens causing bronchial asthma
worldwide. The prevalence of these allergens among
subjects with asthma varies from 45% to 85%, and
sensitivity to mites is a risk factor for asthma. In 1984,
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the first RAST study in asthmatic children in Taiwan
was conducted by Hsieh,8 who showed that D. farinae
(90.2% of patients) was one of the most common
allergens in asthmatic children aged < 16 years. This is
similar to our finding (93.2% of asthmatic patients
aged < 20 years had antibodies against D. pteronyssinus),
and indicates that house dust mites are very common
aeroallergens in young asthmatic patients. In contrast,
the prevalence of antibodies to mite allergens in adult
and elderly asthmatic patients has not yet been well
explored. In our studies, the sensitivity to mites was
comparatively weak in aged patients, for unknown
reasons. Nor can we explain why male rather than
female asthmatic patients had higher rates of antibody
positivity, although sex hormones may play some role
in allergic conditions.
Custovic et al9 showed that the clinical activity and
severity of asthma in mite-sensitive patients are related
to exposure to mite allergens in the dust reservoir, with
levels in beds being an important indicator of disease
activity. However, no study has found an association
between specific antibody concentrations against mites
and asthma severity or airway obstruction. Our study
found no significant difference in antibody levels
against mites in 4 groups of patients with different
severities of asthma; nor did we find any correlation
between airway obstruction (FEV1) and an increase in
IgE antibody levels against mites. The findings were
similar for other allergenic trigger factors. Although
mites are a very common allergenic trigger factor,
asthma severity is affected not by a single factor, but by
the sum of effects due to both allergenic and non-
allergenic trigger factors.
Cockroaches have been identified and recognized
as a major cause of asthma.10 In 1988, Lan et al11
documented that 39.2% of 79 atopic patients in the
Taichung area of Taiwan had IgE antibodies against
cockroach. In 1984, Hsieh8 found antibodies to cock-
Table 4. Asthma severity in relation to the proportions of patients positive for antibodies to specific mite allergens, and
mean (( standard deviation [SD]) antibody titers; data for 111 asthmatic patients
Asthma severity
Mild intermittent Mild persistent Moderate persistent Severe persistent
Number of Mean ((  SD) Number of Mean ((  SD) Number of Mean (( SD) Number of Mean ((  SD)
antibody-positive antibody titer antibody-positive antibody titer antibody-positive antibody titer antibody-positive antibody titer
patients (%) (kU/L) patients (%) (kU/L) patients (%) (kU/L) patients (%) (kU/L)
Dermatophagoides 28/38 (73.7) 31.0 ( 32.7 5/10 (50) 24.8 ( 30.7 30/42 (71.4) 34.4 ( 34.5 15/21 (71.4) 24.0 ( 33.6
pteronyssinus
Dermatophagoides 27/38 (71.1) 25.2 ( 28.9 5/10 (50) 27.1 ( 35.7 29/42 (69.0) 32.4 ( 33.5 13/21 (61.9) 24.5 ( 32.0
farinae
Dermatophagoides 26/34 (76.5) 24.1 ( 28.5 5/10 (50) 25.5 ( 29.0 27/39 (69.2) 32.2 ( 33.5 14/21 (66.7) 22.3 ( 29.1
microceras
roach in 17.9% of asthmatic children aged < 16 years
in the Taipei area. Our finding of antibodies to cock-
roach in 38.3% of asthmatic patients in the Taipei
area is similar to that of Tsai et al12 in 1998, who
reported that 36.4% of asthmatic patients were hyper-
sensitive to German cockroach in the same area.
Our study also found sensitivity to dog dander
(26.3% of patients) and cat dander (10%) across asth-
matic patients of all ages, whereas Hsieh8 reported
sensitivity to dog and cat dander in 8.2% and 7.4%,
respectively, of asthmatic children aged < 16 years.
The greater rates of antibody positivity against dog
and cat dander in our study, compared with the rates
in the Hsieh study,8 can be attributed to the presence
of more pets in Taipei City than previously.
Various fungal spores have been implicated as trigger
factors in asthmatic patients.13 Indeed, our study found
antibodies to the following microbes in such patients:
C. albicans (13.3% of patients), C. herbarum (6.6%),
and A. tenuis (3.5%). In Germany, sensitization to C.
albicans was found in 25% of asthmatics, whereas that
to molds was found in 36%.14 The prevalence of allergy
to fungi in asthmatic patients in Taiwan seems to be
lower than that in Western countries.
Aspirin allergy has been found in 7.1% of a popula-
tion of asthmatic patients, and in 3–8% of asthmatic
patients, ingestion of aspirin or other non-steroidal
anti-inflammatory drugs caused profound, sometimes
life-threatening, bronchoconstriction, and naso-ocular,
dermal, and gastrointestinal responses.15 This prevalence
of aspirin sensitivity is similar to that found in a study
conducted in Finland which showed that 8.8% of
asthmatic patients had aspirin intolerance.16
About 50% of children worldwide are exposed to
environmental tobacco smoke, which in turn
exacerbates asthma in 20% of children with the
condition.17 Our study showed that 18% of asthmatic
patients are smokers, and clearly, major efforts are
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needed to educate asthmatic patients to stop smoking.
Approximately 2-thirds of asthmatic patients revealed
that some of their relatives also have asthma; hence,
this finding supports previous data that genetic factors
play a key role in asthma.18
Non-allergenic trigger factors are difficult to
evaluate with scientific clinical tests. Thus, in this trial,
a detailed questionnaire was completed and diary card
records from a 4-year period were evaluated to identify
the most likely trigger factors. Our findings show that
inhalation of stimulants in the air (94.6% of patients),
respiratory tract infection (92.2%), exercise (75.2%),
and emotional factors (58.8%), are very common non-
allergenic trigger factors for asthma. Exacerbation of
asthma in adults is frequently associated with a
respiratory tract viral infection (RTVI).19 Our results
showed that 92.2% of asthmatic patients had previously
had an asthma attack induced by a respiratory tract
infection, and earlier studies showed that 55–89% of
asthma exacerbations were associated with an
RTVI.20,21 In addition, exercise appeared to cause
bronchoconstriction in 70–80% of asthmatic patients,22
which is similar to our finding of 75.2%.
In conclusion, the common inhaled allergens
causing asthma in Taipei City were, in descending
order, mites, cockroach, dog dander, C. albicans, cat
dander, C. herbarum, and A. tenuis. Non-allergenic
trigger factors were, in descending order, airborne
stimulant inhalation, respiratory tract infection,
exercise, emotional factors, and chemical agents and
drugs. Exposure to mites is an important allergenic
trigger factor in young, particularly male, asthmatic
patients, whereas non-allergenic factors are important
in adult asthmatics, especially the elderly. In the absence
of a correlation between antibody titers against specific
allergens and asthma severity, we suggest that all
trigger factors can contribute to asthma severity. Efforts
should, therefore, be made to identify all possible
trigger factors so that exposure to them can be avoided
and asthma exacerbations reduced.
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